Prednisolone treatment induces tolerogenic dendritic cells and a regulatory milieu in myasthenia gravis patients.

MLA

Luther, Claudia, et al. “Prednisolone Treatment Induces Tolerogenic Dendritic Cells and a Regulatory Milieu in Myasthenia Gravis Patients.” Journal of Immunology (Baltimore, Md. : 1950), vol. 183, no. 2, July 2009, pp. 841–48. EBSCOhost, https://doi.org/10.4049/jimmunol.0802046.

APA

Luther, C., Adamopoulou, E., Stoeckle, C., Brucklacher-Waldert, V., Rosenkranz, D., Stoltze, L., Lauer, S., Poeschel, S., Melms, A., & Tolosa, E. (2009). Prednisolone treatment induces tolerogenic dendritic cells and a regulatory milieu in myasthenia gravis patients. Journal of Immunology (Baltimore, Md. : 1950), 183(2), 841–848. https://doi.org/10.4049/jimmunol.0802046

Chicago

Luther, Claudia, Eleni Adamopoulou, Christina Stoeckle, Verena Brucklacher-Waldert, Daniela Rosenkranz, Lars Stoltze, Sigrid Lauer, Simone Poeschel, Arthur Melms, and Eva Tolosa. 2009. “Prednisolone Treatment Induces Tolerogenic Dendritic Cells and a Regulatory Milieu in Myasthenia Gravis Patients.” Journal of Immunology (Baltimore, Md. : 1950) 183 (2): 841–48. doi:10.4049/jimmunol.0802046.